'Tis the middle of the week and that means we are all caught up in meetings, deadlines and projects. Of course, there are always conferences. In fact, we will break shortly to speak at thePharmaceutical Regulatory and Compliance Congress ( look here) about the usual - pharma and blogging. We appear right after former FDA commish Mark McClellan, in fact. But we promise not to be gone long. Meanwhile, here are a few items to tide you over...
Bayer Profit Falls On Tax Benefit (Bloomberg News)
Schering-Plough's Sugammadex Beats The Competition (Associated Press)
Swiss Approve Novartis Blood Pressure Drug (Reuters)
Cephalon Boosts Its Full-Year Forecast (TheSteet.com)
Parexel Slides As Spending Slows (Forbes)